Summary
Sun Pharma Advanced Research Company share holding pattern reports the following shareholding: Sun Pharma Advanced Research Company Total Promoters is at 65.67%, Mutual Fund at 0.85%, Insurance at 0.00%, Foreign Institutional Investors at 2.04%, Domestic Institutional Investors at 0.02%, and Retail at 31.42%. This breakdown provides a quick snapshot of ownership distribution for Sun Pharma Advanced Research Company share holding pattern in 2026-27.
Sun Pharma Advanced Research Company FAQs
As of 05-2026, the promoter shareholding in Sun Pharma Advanced Research Company stands at 65.67% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Sun Pharma Advanced Research Company is 2.04% and 0.02% respectively.
The retail shareholding of the Sun Pharma Advanced Research Company is 31.42%.
Changes in shareholding patterns of Sun Pharma Advanced Research Company can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Sun Pharma Advanced Research Company are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Sun Pharma Advanced Research Company Associated Pages
- Sun Pharma Advanced Research Company Share Price
- Sun Pharma Advanced Research Company Share Price chart
- Sun Pharma Advanced Research Company Fundamental Analysis
- Sun Pharma Advanced Research Company Technical Analysis
- Sun Pharma Advanced Research Company Peer Comparison
- Sun Pharma Advanced Research Company Share Price History
- Sun Pharma Advanced Research Company Board of Directors
